← Back to directory

Jaime Rodriguez‐Canales

Researcher Next ID · RN-028511

Researcher · Medicine

Erasmus Hospital

Brussels, Colombia

Not currently recruitingFunding unknown
Works count
448
Citation count
17,815
H-index
63
i10-index
156

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Cancer Immunotherapy and Biomarkers
Lung Cancer Treatments and Mutations
RNA modifications and cancer
Radiomics and Machine Learning in Medical Imaging
Immunotherapy and Immune Responses

Publications

  • Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial

    The Lancet · 2021 · 10.1016/s0140-6736(20)32554-x

  • The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

    Journal for ImmunoTherapy of Cancer · 2020 · 10.1136/jitc-2019-000155

  • CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

    Cancer Discovery · 2018 · 10.1158/2159-8290.cd-17-1033

  • STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma

    Cancer Discovery · 2018 · https://doi.org/10.1158/2159-8290.cd-18-0099

  • Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

    Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2017.75.8219

  • Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues

    Scientific Reports · 2017 · 10.1038/s41598-017-13942-8

  • TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence

    Cancer Discovery · 2017 · 10.1158/2159-8290.cd-17-0256

  • CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells

    Nature · 2017 · 10.1038/nature22359

  • Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

    The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30624-1

  • An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer

    Clinical Cancer Research · 2016 · 10.1158/1078-0432.ccr-15-2900

  • Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis

    Cell Reports · 2016 · 10.1016/j.celrep.2016.07.009

  • Diagnosis and Molecular Classification of Lung Cancer

    Cancer treatment and research · 2016 · 10.1007/978-3-319-40389-2_2

  • Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome

    Proceedings of the National Academy of Sciences · 2016 · 10.1073/pnas.1521812113

  • XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer

    Nature · 2016 · 10.1038/nature19771

  • Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

    Annals of Oncology · 2016 · 10.1093/annonc/mdw436

  • Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis

    Journal of Thoracic Oncology · 2016 · 10.1016/j.jtho.2016.10.017

  • A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition

    Clinical Cancer Research · 2015 · 10.1158/1078-0432.ccr-15-0876

  • Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival

    Cancer Research · 2015 · 10.1158/0008-5472.can-14-2535

  • Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma

    Journal of Clinical Investigation · 2015 · 10.1172/jci74725

  • Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma

    Molecular Cancer Research · 2015 · 10.1158/1541-7786.mcr-15-0307

  • A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors

    Nature Genetics · 2014 · 10.1038/ng.3016

  • Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

    Nature Immunology · 2011 · 10.1038/ni.1995

  • Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases

    Modern Pathology · 2011 · 10.1038/modpathol.2011.102

  • Typical and Atypical Pulmonary Carcinoid Tumor Overdiagnosed as Small-Cell Carcinoma on Biopsy Specimens

    The American Journal of Surgical Pathology · 2005 · 10.1097/01.pas.0000149690.75462.29

  • Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer

    Journal of Clinical Oncology · 2005 · 10.1200/jco.2005.02.0818

Current projects

    No projects listed.